Loading company
Latest annual · FY2025
Millions- Total revenues
- 31
- Gross profit
- 18
- Operating income
- (5)
- Net income
- (6)
Latest quarter · Q4 FY2025
Millions- Total revenues
- 9
- Gross profit
- 6
- Operating income
- 0
- Net income
- 0
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -5.3%
- Revenue, 5 yearsFY2020 to FY2025
- +5.9%
- Net income, 5 yearsFY2020 to FY2025
- n/m
STRATA Skin Sciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $30.7 million | $33.6 million | -8.5% | 10-K 2026-03-26 · proof |
| Gross profit | $17.9 million | $19.2 million | -7% | 10-K 2026-03-26 · proof |
| Operating income | -$4.7 million | -$9.3 million | 10-K 2026-03-26 · proof | |
| Net income | -$6.3 million | -$10.1 million | 10-K 2026-03-26 · proof | |
| Cash from operating activities | -$2.8 million | $188,000 | -1,586.2% | 10-K 2026-03-26 · proof |
| Free cash flow | -$4.3 million | -$1.4 million | 10-K 2026-03-26 · proof | |
| Total assets | $30.5 million | $34.9 million | -12.6% | 10-K 2026-03-26 · proof |
| Total liabilities | $27.6 million | $30 million | -7.8% | 10-K 2026-03-26 · proof |
| Cash and cash equivalents | $7.9 million | $7.3 million | +9% | 10-K 2026-03-26 · proof |
| Total debt | $15.3 million | $15.2 million | +1% | 10-K 2026-03-26 · proof |
- What was STRATA Skin Sciences, Inc.'s revenue in fiscal 2025?
- STRATA Skin Sciences, Inc. reported revenue of $30.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $33.6 million the year before (-8.5%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was STRATA Skin Sciences, Inc.'s gross profit in fiscal 2025?
- STRATA Skin Sciences, Inc. reported gross profit of $17.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $19.2 million the year before (-7%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was STRATA Skin Sciences, Inc.'s operating income in fiscal 2025?
- STRATA Skin Sciences, Inc. reported operating income of -$4.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$9.3 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was STRATA Skin Sciences, Inc.'s net income in fiscal 2025?
- STRATA Skin Sciences, Inc. reported net income of -$6.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$10.1 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was STRATA Skin Sciences, Inc.'s cash from operating activities in fiscal 2025?
- STRATA Skin Sciences, Inc. reported cash from operating activities of -$2.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $188,000 the year before (-1,586.2%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was STRATA Skin Sciences, Inc.'s free cash flow in fiscal 2025?
- STRATA Skin Sciences, Inc. reported free cash flow of -$4.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.4 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are STRATA Skin Sciences, Inc.'s total assets?
- As of Dec 31, 2025, STRATA Skin Sciences, Inc. reported total assets of $30.5 million, against $34.9 million a year earlier (-12.6%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are STRATA Skin Sciences, Inc.'s total liabilities?
- As of Dec 31, 2025, STRATA Skin Sciences, Inc. reported total liabilities of $27.6 million, against $30 million a year earlier (-7.8%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are STRATA Skin Sciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2025, STRATA Skin Sciences, Inc. reported cash and cash equivalents of $7.9 million, against $7.3 million a year earlier (+9%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What is STRATA Skin Sciences, Inc.'s total debt?
- As of Dec 31, 2025, STRATA Skin Sciences, Inc. reported total debt of $15.3 million, against $15.2 million a year earlier (+1%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1051514&period_type=annual&limit=5"Information only, not investment advice.